Holen Sie sich die Stockscreener-App
19.99
4.88%
0.93
Handel nachbörslich:
19.72
-0.27
-1.35%
Schlusskurs vom Vortag:
$19.06
Offen:
$19.49
24-Stunden-Volumen:
180.27K
Relative Volume:
1.76
Marktkapitalisierung:
$250.41M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-31.48M
KGV:
-19.22
EPS:
-1.04
Netto-Cashflow:
$-28.71M
1W Leistung:
+11.24%
1M Leistung:
+65.07%
6M Leistung:
+135.45%
1J Leistung:
+24.32%
1-Tages-Spanne:
$18.34
$20.00
1-Wochen-Bereich:
$18.00
$21.99
52-Wochen-Spanne:
$4.90
$28.68
Forte Biosciences Inc Stock (FBRX) Company Profile
Firmenname
Forte Biosciences Inc
Sektor
Branche
Telefon
(310) 618-6994
Adresse
3060 PEGASUS PARK DRIVE, DALLAS, CA
Vergleichen Sie FBRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FBRX
Forte Biosciences Inc
|
19.99 | 238.76M | 0 | -31.48M | -28.71M | -1.04 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.82 | 107.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.32 | 80.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.80 | 57.37B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.93 | 55.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
209.02 | 44.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
Forte Biosciences Inc Stock (FBRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-18 | Eingeleitet | Guggenheim | Buy |
| 2025-01-21 | Eingeleitet | TD Cowen | Buy |
| 2024-04-08 | Hochstufung | Ladenburg Thalmann | Neutral → Buy |
| 2021-09-20 | Hochstufung | Chardan Capital Markets | Sell → Buy |
| 2021-09-03 | Herabstufung | B. Riley Securities | Buy → Neutral |
| 2021-09-03 | Herabstufung | Chardan Capital Markets | Buy → Sell |
| 2021-09-03 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
| 2021-09-03 | Herabstufung | Truist | Buy → Hold |
| 2021-05-14 | Eingeleitet | B. Riley Securities | Buy |
| 2021-03-26 | Eingeleitet | Citigroup | Buy |
| 2020-08-28 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2020-08-25 | Eingeleitet | Truist | Buy |
Alle ansehen
Forte Biosciences Inc Aktie (FBRX) Neueste Nachrichten
Forte Biosciences initiated with an Outperform at Evercore ISI - TipRanks
Evercore ISI initiates coverage on Forte Biosciences stock with Outperform rating - Investing.com
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules - Enidnews.com
Forte Biosciences Inc. (FBRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Is Forte Biosciences Inc a good long term investmentHead and Shoulders Patterns & Small Investment Big Gains - earlytimes.in
What analysts say about Forte Biosciences Inc stockVolume Spike Alerts & Affordable Market Trading - earlytimes.in
Why Forte Biosciences Inc. (37T) stock is a strong buy callQuarterly Earnings Report & Technical Pattern Recognition Alerts - newser.com
What analyst consensus implies for Forte Biosciences Inc. (37T) stockJuly 2025 Analyst Calls & Real-Time Volume Spike Alerts - newser.com
What is Chardan Capital’s Estimate for FBRX FY2025 Earnings? - Defense World
Why Forte Biosciences Inc. (37T) stock appears on watchlists2025 Support & Resistance & Safe Entry Zone Tips - newser.com
Will Forte Biosciences Inc. stock gain from lower inflationJuly 2025 Intraday Action & AI Driven Stock Movement Reports - newser.com
What downside risks could hit Forte Biosciences Inc. (37T) stockLong Setup & Community Trade Idea Sharing - newser.com
Can Forte Biosciences Inc. (37T) stock deliver strong annual returnsJuly 2025 Setups & Low Risk Profit Maximizing Plans - newser.com
Is Forte Biosciences Inc. (37T) stock vulnerable to rate hikes2025 Price Targets & Safe Entry Momentum Stock Tips - newser.com
Will Forte Biosciences Inc. (37T) stock profit from AI boomJuly 2025 Spike Watch & Free Reliable Trade Execution Plans - newser.com
Published on: 2025-11-19 14:11:29 - newser.com
What drives Forte Biosciences Inc stock priceMid Cap Growth Trends & Budget Friendly Growth Tips - earlytimes.in
Why Forte Biosciences Inc. stock is in analyst buy zoneMarket Risk Summary & Technical Buy Zone Confirmations - newser.com
Developing predictive dashboards with Forte Biosciences Inc. data2025 Volume Leaders & Weekly Return Optimization Alerts - newser.com
Chardan Capital Reaffirms “Buy” Rating for Forte Biosciences (NASDAQ:FBRX) - Defense World
How analysts revise price targets for Forte Biosciences Inc. (37T) stock2025 Market Trends & Scalable Portfolio Growth Methods - newser.com
Why Forte Biosciences Inc. (37T) stock appeals to dividend investorsWatch List & Real-Time Volume Trigger Notifications - newser.com
Why Forte Biosciences Inc. stock appeals to analystsMarket Movement Recap & Reliable Breakout Forecasts - newser.com
Chardan Capital Maintains Forte Biosciences (FBRX) Buy Recommendation - Nasdaq
Chardan Capital Maintains Buy Rating for FBRX at $61 Target | FB - GuruFocus
Published on: 2025-11-17 02:42:28 - newser.com
Will Forte Biosciences Inc. stock outperform growth indexesEarnings Recap Summary & Safe Investment Capital Preservation Plans - newser.com
Finanzdaten der Forte Biosciences Inc-Aktie (FBRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.53%
1.88%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):